发明名称 (+) NALOXONE AND EPINEPHRINE COMBINATION THERAPY
摘要 A composition formulated for dose-wise delivery to a breathing passageway of a human, the composition comprising a carrier solution containing (+)naloxone and a pharmacologically effective amount of at least one adrenergic agonist, the (+)naloxone and agonist forming a mixture in the carrier. The at least o ne adrenergic agonist is selected from the group consisting of epinephrine, isoproterenol, abluterol, aminophyline, beclomethasone, dyphylline, flunisolide, isoetharine, metaproterenol, oxtriphylline terbutaline, theophylline, pseudoephedrine, phenylephrine, ephedrine and norepinephrine. That composition is delivered by an atomizer means such as a liquid sprayer or inhaler to treat nasal congestion and asthmatic attacks. Further provided by the invention is a cardiovascular and respiratory stimulating composition fo r administration to a patient in doses, the composition comprising a pharmacologically effective concentration of (+)naloxone in a carrier solution. If necessary, the composition may also contain a pharmacologically effective amount of at least one adrenergic agonist.
申请公布号 CA2407285(A1) 申请公布日期 2001.11.08
申请号 CA20012407285 申请日期 2001.04.03
申请人 SURE MEDICAL, INC. 发明人 CAFFREY, JAMES L.
分类号 A61K9/00;A61K31/135;A61K31/44;A61K31/52;(IPC1-7):A61K31/52 主分类号 A61K9/00
代理机构 代理人
主权项
地址